FDA adcomm members’ ties to industry under scrutiny

AI justification

[Analyst A judged it not actionable; Analyst B's verdict applied] Systemic industry influence in FDA advisory committees undermines public health governance and patient rights. | The scrutiny itself is a positive step toward accountability, but the underlying issue—systemic industry influence in FDA advisory committees—represents a significant ethical failure. The research exposes a conflict of interest that directly undermines public health governance and patient rights, violating core principl